Table 1 Patient characteristics
From: Exhaled phospholipid transfer protein and hepatocyte growth factor receptor in lung adenocarcinoma
All patients (n = 35) | LUAD (n = 17) | Control (n = 18) | Significance | |
|---|---|---|---|---|
Sex | ||||
Male | 21 (60) | 6 (35) | 15 (83) | p = 0.0059 |
Female | 14 (40) | 11 (65) | 3 (17) | p = 0.0059 |
Age, years | 70 (43–83) | 72 (59–83) | 68 (43–80) | p = 0.3381 |
BMI, kg/m2 | 27.5 (19.6–38.0) | 27.4 (21.1–35.6) | 27.6 (19.6–38.0) | p = 0.8799 |
Comorbidities | ||||
Coronary artery disease | 14 (40) | 2 (12) | 12 (67) | p = 0.0016 |
Diabetes mellitus | 13 (37) | 3 (18) | 10 (56) | p = 0.0354 |
Hypertension | 22 (63) | 8 (47) | 14 (78) | p = 0.0858 |
WHO performance status prior to surgery | ||||
0 | 13 (37) | 9 (53) | 4 (22) | p = 0.0858 |
1 | 15 (43) | 8 (47) | 7 (39) | p = 0.7380 |
2 | 7 (20) | 0 (0) | 7 (39) | p = 0.0076 |
Smoking history | ||||
Current | 2 (6) | 2 (12) | 0 (0) | p = 0.2286 |
Former (> 6 weeks) | 26 (74) | 11 (65) | 15 (83) | p = 0.2642 |
Never | 7 (20) | 4 (23) | 3 (17) | p = 0.6906 |